scispace - formally typeset
Search or ask a question

Answers from top 10 papers

More filters
Papers (10)Insight
However, an increasing body of information suggests that in addition to its cell-cycle inhibitory activity, p21 can affect p53-dependent apoptosis.
Taken together our results suggest that p21 induction does not affect the apoptotic response to nongenotoxic p53 activation.
In conclusion, our data suggest that overexpression of p21 can promote apoptosis, leading to elevated sensitivity to proapoptotic stimuli.
Thus, p21's antiproliferative function is indispensable for the suppression of carcinogenesis from chronically injured liver and renal epithelial cells and cannot be compensated by apoptosis.
Depending on the stress applied, p21 upregulation can either promote apoptosis or prevent against apoptotic injury.
Therefore, we hypothesized that overexpression of p21 mediates apoptosis in human VSMC, in addition to the blockade of cell cycle progression.
The fact that it also occurs in TGCs reveals that p57 and p21 serve nonredundant functions, and suggests that the role of p21 in suppressing apoptosis is restricted to terminally differentiated cells.
In conclusion, p21 regulates proliferation and protects against apoptosis in AECs.
In addition, recent data provide strong evidence for new emerging functions of p21, including a role as a modulator of apoptosis.
We speculate that such up-regulation of p21 contributes to the altered pattern of cell growth and resistance to apoptosis.

Related Questions

What is the role of il-21?4 answersIL-21 plays a crucial role in various immune responses and diseases. It is involved in regulating immune cell differentiation and function, impacting both innate and adaptive immunity. IL-21 promotes the proliferation and differentiation of B cells, influencing germinal center formation and antibody production. Additionally, in the tumor microenvironment, IL-21 contributes to regulatory T cell (Treg) generation, potentially aiding immune evasion in cancer. Furthermore, IL-21 affects T and B cell responses in alloreactivity post-organ transplantation, highlighting its significance in transplant immunology. Overall, IL-21's pleiotropic actions on immune cells underscore its importance in autoimmune diseases, viral infections, cancer immunotherapy, and allogeneic responses after transplantation.
How conserved in p21 in the mouse model?4 answersp21, a critical regulator in various biological processes, exhibits conservation in mouse models. Studies have highlighted its role in senescence, with transgenic mouse models targeting cells expressing high levels of p21 (p21high) to investigate tissue dysfunction in aging and obesity. Additionally, p21 has been implicated in cell cycle regulation, differentiation, and apoptosis, showcasing its significance in determining cell fate. Furthermore, p21's involvement in tumorigenesis has been explored, with contrasting roles identified as both a tumor suppressor and an oncogene in different contexts. The genetic analysis of p21 in mice has provided insights into its functions and potential therapeutic implications, emphasizing the conservation and importance of p21 in mouse models.
Could IL-21 be used therapeutically to enhance anti-tumor immune responses?5 answersIL-21 has been studied as a potential therapeutic agent to enhance anti-tumor immune responses. It plays a central role in the transition from innate immunity to adaptive immunity and has shown substantial tumor regression in mice. IL-21 activates anti-tumor T cell responses, induces B cell activation, and promotes the generation and maintenance of germinal centers and tertiary lymphoid structures. Different dosing regimens of IL-21 have been explored, including dynamically determined dosing according to tumor mass changes, which resulted in efficient disease elimination in melanoma. IL-21 has also been engineered to selectively activate CD8+ T cells, resulting in improved efficacy and safety over untargeted IL-21. Additionally, cis-targeted IL-2 and IL-21 molecules have been developed to selectively activate CAR-T cells, showing strong tumor regression and relapse-free survival in preclinical models. These findings suggest that IL-21 could be used therapeutically to enhance anti-tumor immune responses, particularly in combination with other immunotherapies.
Does P53 inhibition cause cancer?5 answersP53 inhibition does not cause cancer. In fact, the p53 protein is a critical tumor suppressor that plays a role in preventing genome mutations and suppressing tumor growth. However, p53 is frequently mutated in cancer, leading to a loss of function and malfunction along the p53 pathway. There have been efforts to develop strategies to restore normal p53 expression and activity, including the use of small-molecule stabilization of mutant p53 protein and the design of p53 aggregation inhibitors. Additionally, targeting p53 inhibitors has shown promise as an anti-cancer strategy, with the development of small molecules that restore the tumor suppressor function of wild-type p53. Therefore, rather than causing cancer, inhibition of p53 may actually be a potential therapeutic approach for treating p53-mutant cancers.
How does p53 affect p21?5 answersStep 1: Answer without citation P53 affects p21 by forming a complex that influences various cellular functions, including gene expression and stability. The p53/p21 complex is involved in regulating p53-dependent gene expression, and p21 is required for the binding of p53 to the promoters of specific genes. Additionally, p21 negatively regulates p53 stability and promotes the interaction of p53 with Wip1, a phosphatase that facilitates the degradation of p53. Moreover, the p53-p21 pathway can prevent ferroptosis in cancer cells by suppressing the accumulation of toxic lipid ROS and promoting the conservation of the antioxidant glutathione. Step 3: Answer with citation P53 affects p21 by forming a complex that influences various cellular functions, including gene expression and stability. The p53/p21 complex is involved in regulating p53-dependent gene expression, and p21 is required for the binding of p53 to the promoters of specific genes. Additionally, p21 negatively regulates p53 stability and promotes the interaction of p53 with Wip1, a phosphatase that facilitates the degradation of p53. Moreover, the p53-p21 pathway can prevent ferroptosis in cancer cells by suppressing the accumulation of toxic lipid ROS and promoting the conservation of the antioxidant glutathione.
Does apoptosis aid in tumor suppression?10 answers